ArticleRSC advances2026
Sequential crystallization pathways in apatite-wollastonite glass-ceramics
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The clinical performance of next generation bioceramics requires precise control over their multi-phase composition, a goal often unachievable with conventional synthesis routes that lead to stochastic crystallization. Here, we establish a deterministic processing-structure paradigm for apatite-wollastonite glass-ceramics (AWGCs) by using a scalable spray pyrolysis technique to create atomically homogeneous amorphous precursors. By systematically controlling the sintering temperature (700-1100 °C), we decouple the kinetic and thermodynamic drivers of phase formation. High-resolution XRD with Rietveld analysis reveals a predictable, three-stage evolution; kinetically driven hydroxylapatite nucleation (<800 °C), followed by a thermodynamic crossover to a whitlockite-dominant regime (900-1000 °C), and finally the diffusion-controlled growth of mechanically robust wollastonite (>1000 °C). This work presents the first quantitative, predictive map for this system, enabling the rational design of AWGCs with bespoke phase assemblages for targeted biomedical applications, from bioactive coatings to load-bearing implants.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.